
Collaboration - October 16, 2013
Taris Biomedical and AstraZeneca in bladder cancer pact
TARIS Biomedical enters research collaboration with AstraZeneca for improved bladder cancer treatments. TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has entered into a research collaboration with AstraZeneca to evaluate novel treatments for bladder cancer. Under the terms of the […]